Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Ourense (39)

2024

  1. Applicability of the Barcelona scale to assess the quality of cleanliness of mucosa at esophagogastroduodenoscopy

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 246-252

  2. Colonoscopy Satisfaction and Safety Questionnaire based on patient experience (CSSQP): A valuable quality tool for all colonoscopies

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 1, pp. 1-13

  3. Endoscopic surveillance for familial intestinal gastric cancer in low-incidence areas: An effective strategy

    International Journal of Cancer, Vol. 154, Núm. 1, pp. 124-132

  4. Influence of social support and stressful life events on adherence to colorectal cancer screening using faecal occult blood test in Spanish medium risk population

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 1, pp. 14-23

  5. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU

    Revista espanola de enfermedades digestivas, Vol. 116, Núm. 2, pp. 83-113

  6. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 401-432

  7. Optical diagnosis in still images of colorectal polyps: comparison between expert endoscopists and PolyDeep, a Computer-Aided Diagnosis system

    Frontiers in Oncology, Vol. 14

  8. Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps

    United European Gastroenterology Journal

  9. Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 293-318

2023

  1. BMPR2 as a Novel Predisposition Gene for Hereditary Colorectal Polyposis

    Gastroenterology, Vol. 165, Núm. 1, pp. 162-172.e5

  2. Colorectal cancer: From prevention to treatment

    Best Practice and Research: Clinical Gastroenterology

  3. Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study

    United European Gastroenterology Journal, Vol. 11, Núm. 7, pp. 692-699

  4. Germline mutations in WNK2 could be associated with serrated polyposis syndrome

    Journal of Medical Genetics, Vol. 60, Núm. 6, pp. 557-567

  5. Image-enhanced endoscopy in the diagnosis of gastric premalignant conditions and gastric cancer

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 5, pp. 397-409

  6. Impact of the COVID-19 Pandemic on the Diagnosis of Colorectal Cancer within a Population-Based Organized Screening Program

    Cancers, Vol. 15, Núm. 19

  7. Inadequate social support decreases survival in decompensated liver cirrhosis patients

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 1, pp. 28-38

  8. Perceived barriers and benefits in the participation in faecal occult blood test colorectal cancer screening programme

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 3, pp. 185-194

  9. Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)

    PLoS Medicine, Vol. 20, Núm. 10

  10. Targeted depletion of pks+ bacteria from a fecal microbiota using specific antibodies

    mSystems, Vol. 8, Núm. 3, pp. e0007923

2022

  1. Comparative analysis of capture methods for genomic profiling of circulating tumor cells in colorectal cancer

    Genomics, Vol. 114, Núm. 6